Abstract
Background: Breast cancer (BC) subtypes have different survival and response to therapy. We studied predictors of central nervous system metastases (CNS-M) and outcome after CNS-M diagnosis according to tumor subtype. Patients and methods: 488 patients with diagnosis of metastatic BC were retrospectively evaluated. According to the combination of hormone receptors (HR) and HER2 status, tumors were grouped in: Luminal (Lum), Luminal/HER2+, pure HER2-positive (pHER2+) and triple negative (TN). Time to CNS progression, CNS-M free interval and Overall Survival (OS) after CNS-M occurrence were compared by the log-rank test. Cox-proportional hazard models were used to study predictor factors associated with CNS progression, including tumor subtype and all potentially clinical relevant variables. Results: 115 patients (pts) developed CNS-M with a median time to CNS progression of 31 months. The rate of CNS-M by subtype was: Lum 14%, Lum/HER2+ 35%, pHER2+ 49%, TN 22% (. p
Original language | English |
---|---|
Pages (from-to) | 623-628 |
Number of pages | 6 |
Journal | Breast |
Volume | 23 |
Issue number | 5 |
DOIs | |
Publication status | Published - Oct 1 2014 |
Keywords
- BC subtypes
- Brain metastases
- Breast neoplasms
- Survival outcome
ASJC Scopus subject areas
- Surgery
- Medicine(all)